Search results
Author(s):
Aneil Malhotra
,
Sanjay Sharma
Added:
3 years ago
Athletes who perform regular and intensive exercise regimes develop a variety of electrical and structural cardiac adaptations that manifest functionally to improve stroke volume and performance. Up to one-fifth of young athletes (aged between 14–35 years) reveal greater left ventricular (LV) wall thickness compared to sedentary controls, though the majority fall under 12 mm.1,2 A small…
View more
Author(s):
Uchenna Ozo
,
Sanjay Sharma
Added:
3 years ago
Athletes may occasionally succumb to sudden cardiac arrest because of a quiescent cardiac abnormality. These catastrophes are rare, affecting between 1 in 17,000 to 1 in 50,000 athletes, depending on the sporting discipline.1,2 Most deaths affect male athletes participating in explosive sports of a start–stop nature, such as basketball and soccer, and occur during or immediately after exercise.1…
View more
John Rawlins
Job title: Consultant Interventional Cardiologist
Author
Sudden Cardiac Death in Athletes
Author(s):
Andrew D’Silva
,
Michael Papadakis
Added:
3 years ago
Article
Author(s):
Luokai Wang
,
Tee Joo Yeo
,
Benedict Tan
,
et al
Added:
2 years ago
Author(s):
Cristina Basso
,
Gaetano Thiene
Added:
3 years ago
Despite the low prevalence in the overall population, congenital coronary artery (CA) anomalies are frequently found as the cause of sudden death (SD) in the young, particularly in the athletic field.1-11 These anomalies are observed both in paediatric and adult patients, with an equal incidence of SD. Why a patient may survive asymptomatic until adulthood and then suffer from angina, myocardial…
View more
Author(s):
Daniel X Augustine
,
Tracey Keteepe-Arachi
,
Aneil Malhotra
Added:
3 years ago
Author(s):
Alexandros Klavdios Steriotis
,
Sanjay Sharma
Added:
3 years ago
Hypertrophic cardiomyopathy (HCM) is a hereditary primary myocardial disease that is most commonly caused by mutations within genes encoding sarcomeric contractile proteins and is characterised by left ventricular hypertrophy in the absence of a cardiac or systemic cause.1,2 The condition is inherited as an autosomal dominant trait and has a prevalence of one in 500.3,4 Marked genetic…
View more